Search

everythinglearnresearchcommunity

for

Search:↓

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Exosome-based therapies show promise for treating alopecia areata but need more research.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Hair loss can occur after treating diabetic ketoacidosis, especially with rapid weight loss and high soft drink intake.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

RANKL causes lymph nodes to grow by making certain cells multiply.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Early hair graying is often inherited and influenced by genetics, environment, and lifestyle, but treatment options are limited.

Vitamin D may help reduce thyroid antibodies and improve thyroid function in Hashimoto's Thyroiditis.

Skin stretching can improve vaccine delivery through hair follicles and boost immune response.

Nanotechnology can improve tissue healing by controlling immune responses.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

DPCP is effective for treating severe alopecia areata, but relapse is common.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Careful management of blood thinners is crucial for lupus patients with APS.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

Terbinafine can cause hair loss.

Cyclosporin doesn't stop hair loss.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.